Industry Symposium by GE HealthCare
IND 6 - Getting ready for neuroimaging in the new era of amyloid targeting therapies
During this symposium you will learn about Amyloid Related Imaging Abnormalities (ARIA) management and the evolving role of PET biomarkers in Alzheimer's treatment . You will also gain insights into current amyloid therapies and cutting-edge imaging advancements, that will help you determine your patient’s pathology as well as the right treatment path.
20 min
Detection and management of ARIA – a new challenge for the radiologist.
Frederik Barkhof, Amsterdam / Netherlands
20 min
The role of PET biomarkers: From confirming Alzheimer’s Disease pathology to future therapy management.
Alexander Drzezga, Cologne / Germany
15 min
Panel Discussion
Paul Michael Evans, London / United Kingdom
Anja Mett, Na / Switzerland
Anja Mett, Na / Switzerland
Lectures
1
Detection and management of ARIA – a new challenge for the radiologist.
20:00Frederik Barkhof, Amsterdam / NL
2
The role of PET biomarkers: From confirming Alzheimer’s Disease pathology to future therapy management.
20:00Alexander Drzezga, Cologne / DE
3
Panel Discussion
15:00Anja Mett, Na / CH
Paul Michael Evans
London / United Kingdom
Frederik Barkhof
Amsterdam / NetherlandsAlexander Drzezga
Cologne / GermanyPaul Michael Evans
London / United KingdomAnja Mett
Na / Switzerland